Cancer cases are globally on the rise, causing an increasing demand for their treatment. As a response, Heraeus Pharmaceutical Ingredients expanses its production capacities for Platinum-based Highly Potent Active Pharmaceutical Ingredients (Pt hAPIs).
Construction of the new production line is already under way at the company’s headquarters in Hanau, Germany. With the multi-million Euro investment, Heraeus reinforces its worldwide market leadership position in this field, underscoring the company’s long tradition in top-quality precious metal technologies. The new expansion will further increase the company's market share.